Skip to main content
OpenTrials
Completed

NCT Number: NCT01957839

Color Doppler Analysıs Of Uterin And Intraovarian Blood Flow Before And After Treatment Wıth Cabergoline In Hyperprolactinemic Patients

the investigators examined the hypothesis that hyperprolactinemia may alter uterin, endometrial and intraovarian blood flow and may contribute to increased infertility by another way.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Adverse Reaction to Other Drugs and Medicines

Age range

18 year–40 year

Sex eligibility

Female

Study type

Interventional

Phase

Phase 4

Primary location

Sisli Etfal Teaching Hosital

Şişli, Turkey (Türkiye)

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Women who had blood prolactin level higher than 25ng/dl

Exclusion criteria

  • Pregnancy
  • Use of drugs effecting vasculature such as hormonal therapy, oral contraceptives, antihypertensives
  • Diseases like pelvic inflammatory disease and systemic hypertension
  • Women with clinically overt or treated cardiovascular disease
  • Concurrent illness other than hyperprolactinemia

Treatment and study plan

cabergoline treatment

Drug

cabergoline treatment for hyperprolactinemia group

Primary outcomes

  1. th effect of prolactin vascular flow and resistance

    Time frame: the effect of prolactin in vascular resistance at 2 weeks after treatment

Sponsors and collaborators

Lead sponsor

Istanbul Bakirkoy Maternity and Children Diseases Hospital

Other Gov

Registry information

Important dates

Study start
2010
Primary completion
2011
Study completion
2011
First posted
Oct 8, 2013
Registry last updated
Oct 8, 2013

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.